From the Guidelines
Topiramate is recommended for the prevention of episodic and chronic migraine, with a suggested dosing regimen starting at 25 mg once daily for the first week, then gradually increasing by 25 mg weekly until reaching the target dose of 100 mg daily, typically given as 50 mg twice daily 1. The dosing of topiramate for migraine prevention is based on the most recent clinical practice guideline for the management of headache, which suggests its use for the prevention of episodic and chronic migraine 1. Key points to consider when prescribing topiramate for migraine prevention include:
- Starting with a low dose of 25 mg once daily for the first week to minimize side effects
- Gradually increasing the dose by 25 mg weekly until reaching the target dose of 100 mg daily
- Typical dosing is 50 mg twice daily, but some patients may respond to lower doses (50-75 mg daily) or require up to 200 mg daily for optimal effect
- Maintaining adequate hydration to reduce the risk of kidney stones
- Continuing the medication for at least 6 months once effective, after which a gradual taper can be considered to determine if ongoing therapy is needed
- Monitoring patients for common side effects such as paresthesia, cognitive slowing, fatigue, and dizziness The mechanism of action of topiramate involves blocking sodium channels, enhancing GABA activity, and inhibiting glutamate receptors, which collectively help reduce the neuronal hyperexcitability associated with migraines 1.